In Re: National Prescription Opiate Litigation

Track this case

Case overview

Case Number:

1:17-md-02804

Court:

Ohio Northern

Nature of Suit:

P.I.: Other

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

Dan Aaron Polster (MDL 28

Firms

Companies

Government Agencies

Sectors & Industries:

  1. August 20, 2021

    NJ Joins $26B Opioid Settlement With J&J, Pharma Cos.

    New Jersey intends to join a $26 billion settlement with Johnson & Johnson and three pharmaceutical distribution companies in sprawling multidistrict litigation over the companies' roles in the opioid crisis, acting Attorney General Andrew J. Bruck said Friday.

  2. August 18, 2021

    Grocery Chain Wants Out Of Ohio Counties' Opioid Bellwether

    A regional supermarket chain on Tuesday told the Ohio federal judge overseeing the multidistrict litigation over the opioid crisis that it should be let out of public nuisance claims brought by two counties in an upcoming bellwether trial since it has a decadelong history of compliance with anti-diversion laws.

  3. August 17, 2021

    'No End In Sight' As Endo, Arnold & Porter Reveal Opioid Files

    The conduct of Endo Pharmaceuticals and its Arnold & Porter attorneys has thoroughly tainted discovery in multidistrict opioid litigation, an Illinois federal judge heard Tuesday, shortly after new disclosures showed that the law firm was recently threatened with a possible referral to the state bar authorities.

  4. August 13, 2021

    Ohio Counties Don't Want 'Legal Opioid' Talk In Bellwether

    Two Ohio counties set for an October bellwether trial over the opioid crisis want their pharmacy-chain adversaries blocked from calling prescription opioids "legal opioids," saying it will only confuse matters since legality is dependent on context.

  5. August 09, 2021

    Atty Fees Capped At 15% In $26B Opioid MDL Settlement

    An Ohio federal judge has capped contingent attorney fees in a $26 billion settlement in the sprawling opioid multidistrict litigation at 15%, saying the cap is necessary to ensure more money goes to the plaintiffs for addressing the harm opioids have done and to keep fees from being unreasonable.

  6. August 06, 2021

    5 Highlights As Endo, Arnold & Porter Face Opioid Oblivion

    Endo Pharmaceuticals and Arnold & Porter struggled Friday to contain fast-spreading fallout from explosive allegations they hid "damning evidence" in opioid litigation, as a New York judge contemplated nuking the drugmaker's entire trial defense and plaintiffs' lawyers argued that the misconduct has damaged opioid cases nationwide.

  7. July 28, 2021

    Opioid Distributors Pin Blame On Others As W.Va. Trial Ends

    Drug distributors ended their bellwether case in West Virginia on Wednesday with a declaration that opioids piled up there because of doctors, legislators, health officials, the DEA — and the state's just plain unhealthy people.

  8. July 28, 2021

    Endo, Arnold & Porter Accused Of Cover-Up In Opioid MDL

    Endo Pharmaceuticals and its Arnold & Porter lawyers are making "incredibly belated" discovery disclosures in multidistrict opioid litigation after a severe punishment for discovery violations in a separate opioid case, and an explanation under oath is needed, an Illinois federal judge heard Wednesday.

  9. July 27, 2021

    'Mountainous' Opioid Shipments Fed Crisis, Judge Told

    Lawyers for a small Appalachian county began closing arguments Tuesday in a West Virginia trial seen as an important test of liability for the opioid epidemic, arguing that the "Big Three" drug distributors' "mountainous" shipments fed multiple waves of addiction.

  10. July 23, 2021

    Opioid Wholesalers, W.Va. Gov'ts Set To Wrap Bellwether

    A two-day closing marathon in a bellwether opioid crisis trial in West Virginia federal court is set to start Tuesday after the city and county at the heart of the case battled in recent days to reinforce their position that distributors weren't invisible middlemen but causes of the problem.